Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically modified filamentous phage as bactericidal agents: a pilot study.

S Hagens1, U Bläsi

  • 1Department of Microbiology and Genetics, Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Vienna, Austria.

Letters in Applied Microbiology
|September 13, 2003
PubMed
Summary

Genetically engineered phages efficiently kill bacteria without cell lysis, minimizing endotoxin release. This offers a safer strategy for using bacteriophage therapy against infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modification of translation factor aIF5A from Sulfolobus solfataricus.

Extremophiles : life under extreme conditions·2018
Same author

Bacteriophage applications: where are we now?

Letters in applied microbiology·2010
Same author

Cloning, purification, and crystallization of a bacterial gene expression regulator--Hfq protein from Escherichia coli.

Biochemistry. Biokhimiia·2002
Same author

Evidence against an Interaction between the mRNA downstream box and 16S rRNA in translation initiation.

Journal of bacteriology·2001
Same author

Modulation of ribosomal recruitment to 5'-terminal start codons by translation initiation factors IF2 and IF3.

FEBS letters·2001
Same author

Dimerization between the holin and holin inhibitor of phage lambda.

Journal of bacteriology·2000

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biotechnology

Background:

  • Bacteriophage therapy is a promising alternative to antibiotics.
  • Conventional lytic phages cause host cell lysis, releasing endotoxins.
  • Controlling endotoxin release is crucial for safe phage applications.

Purpose of the Study:

  • To assess the efficacy of engineered filamentous phages in killing bacteria.
  • To determine if engineered phages can prevent host-cell lysis.
  • To evaluate endotoxin release compared to lytic phages.

Main Methods:

  • Engineered M13 phage expressing lethal proteins (BglII or lambda S holin) were used.
  • Infection of growing Escherichia coli cultures.
  • Bacterial survival and endotoxin levels were quantified.

Related Experiment Videos

Main Results:

  • Engineered phages demonstrated high bacterial killing efficiency.
  • Infected bacterial cells remained structurally intact.
  • Significantly reduced endotoxin release compared to lytic phage infection.

Conclusions:

  • Genetically engineered phages can effectively kill bacteria without lysis.
  • This approach minimizes pyrogenic cell wall component release.
  • Engineered phages represent a viable strategy for safer bactericidal applications.